author-photo

Jennifer W. Oliver

University of Rochester

5

Papers

313

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Phase II Results of Bendamustine in Combination with Rituximab in Relapsed Indolent and Mantle-Cell Non-Hodgkin’s Lymphoma.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (7)
A phase II, multicenter study of bendamustine HCl plus rituximab in relapsed indolent B-cell and mantle-cell non-Hodgkin’s lymphoma (NHL)

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (21)
Bendamustine HCl (TREANDATM) Treatment Results in High Rates of Objective Response in Patients with Rituximab-Refractory and Alkylator-Refractory Indolent B-Cell Non-Hodgkin’s Lymphoma (NHL): Results from a Phase II Multicenter Single-Agent Study (SDX-105-01).

2005 Blood
Show All
- Source
- Cite
- Save
Citations (14)
Bendamustine HCl (TREANDA TM ) Treatment in Combination with Rituximab Results in Objective Responses in Patients with Refractory/Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin’s Lymphoma: Results from Phase II Multicenter Study (SDX-105-02).

2005 Blood
Show All
- Source
- Cite
- Save
Citations (7)